Woodley Farra Manion Portfolio Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,488
Closed -$237K – 125
2025
Q4
$237K Buy
+2,488
New +$244K 0.01% 106
2025
Q3
– Sell
-1,988
Closed -$214K – 119
2025
Q2
$214K Sell
1,988
-66
-3% -$6.68K 0.01% 110
2025
Q1
$207K Buy
+2,054
New +$207K 0.01% 109
2020
Q3
– Sell
-3,545
Closed -$124K – 125
2020
Q2
$124K Sell
3,545
-82
-2% -$2.95K 0.01% 94
2020
Q1
$118K Sell
3,627
-20
-0.5% -$781 0.01% 97
2019
Q4
$165K Buy
+3,647
New +$153K 0.02% 98

Other funds holding BSX

Woodley Farra Manion Portfolio Management's BSX Position: Q1 2026 in Review

Woodley Farra Manion Portfolio Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,488 shares — an estimated $237K sold.

Woodley Farra Manion Portfolio Management first reported a position in BSX in Q4 2019 and held it in 6 quarters. The position peaked at $237K in Q4 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Woodley Farra Manion Portfolio Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 2,488 Boston Scientific shares in Q1 2026, an estimated $237K.
  • Woodley Farra Manion Portfolio Management first reported a position in Boston Scientific in Q4 2019 and held it in 6 quarters.
  • Woodley Farra Manion Portfolio Management's Boston Scientific position peaked at $237K in Q4 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.